Ipilimumab vs Moxifloxacin

## Ipilimumab vs Moxifloxacin: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Moxifloxacin**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Moxifloxacin**: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Moxifloxacin — 12 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Moxifloxacin — C21H24FN3O4.

**Molecular Weight**: Ipilimumab — N/A; Moxifloxacin — 401.4350 g/mol.

**Type**: Ipilimumab — Antibody; Moxifloxacin — Small molecule.